Medicines and healthcare products regulatory agency on 4 november. Headlines trumpeted claims that we might finally have a truly effective pill that prevents severe covid in people who get infected.
Merck’s covid pill might pose risks for pregnant women.
Merck covid pill molnupiravir. Molnupiravir interferes with the virus' ability to replicate inside the body. Merck's covid antiviral drug molnupiravir could cut serious illness and hospitalization. Merck said it's also being studied for its potential to prevent disease in people exposed to the virus.
Merck sharp & dohme corp. But the approval, for people at high risk of severe disease, comes as a prominent virologist has suggested using molnupiravir could do far more harm than good, potentially unleashing new,. Some laboratory studies suggest that molnupiravir can insert errors in dna, which could in theory harm a developing fetus, sperm cells or.
It was later found to also be effective against a virus in the coronavirus family, middle east respiratory syndrome (mers). The pill works like this: Conspiracy theorists have gone so far as to suggest merck is actively downplaying ivermectin, a generic drug that costs around $35 for 20.
On friday, the drug maker released full results from its study of the pill, molnupiravir, showing it reduced the risk of hospitalization by 30%, down from a. Merck's treatment, known as molnupiravir and developed in partnership with ridgeback biotherapeutics, is cleared for use in adults with mild to moderate covid who are at risk for severe disease. News that merck’s antiviral drug molnupiravir had successfully treated coronavirus patients in clinical trials set off celebrations around the world.
Merck’s covid pill could pose serious risks, scientists warn.